This year’s Arvid Carlsson prize for life science entrepreneurs was awarded to Kristina Lagerstedt and Susanne Staaf, who together founded and run 1928 Diagnostics. Last year’s prize winner, Erik Gatenholm, CELLINK, awarded them the prize. “Kristina Lagerstedt and Susanne Staaf are committed entrepreneurs with the ambition to tackle antibiotic resistance. They have developed 1928 Diagnostics into one of Sweden’s hottest startups by deliberately investing in building the right team and thinking globally from day one,” said Marianne Dicander Alexandersson, chairman of Sahlgrenska Science Park and the award jury.
The winners of Arvid Carlsson Award by Sahlgrenska Science Park 2018 are internationally
recognized through a technique that is considered to be pioneer in solving one of the world’s
largest threats to human health. Antibiotic resistance.
With a global mindset from start in 2014, the Gothenburg-based company is already active in
more than ten countries throughout Europe and is now planning future expansion in the US.
The founders show that dedication and true entrepreneurial spirit for a good cause
based on research can make a difference in the world.
Jury: The board of directors Sahlgrenska Science Park
Marianne Dicander Alexandersson, Chairman
Håkan Ahlström, City Manager, The City of Mölndal
Ivan Mijakovic, Professor, Director of the Life Science Engineering Area of Advance Chalmers University of Technology
Cecilia Dalman Eek, Member of the City Council, The City of Gothenburg
Eva Wiberg, Principal, University of Gothenburg
Birgitta Losman, Member The Region Västra Götaland
Ann-Marie Wennberg (adj), Professor and CEO, Sahlgrenska University Hospital